Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member Latest Breaking News General Discussion The DU Lounge All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search
 

denem

(11,045 posts)
Tue Apr 28, 2020, 03:03 PM Apr 2020

Oxford Coronavirus Team: "Nobody is going to make a lot of money off this".

Unlike some other vaccine efforts, Oxford University is not in it for big bucks. Drug manufacturers will be granted (only) non exclusive licenses. Manufacturing is being set up in Britain and the Netherlands before the vaccine has been proven to work.

Phases I trials are underway with 1,100 people. Phase II/III trials with 5,000 will begin next month. If successful, production may begin as early as September.

One of the reasons the team is ahead is their experience is producing MERS and Ebola vaccines.

In Race for a Coronavirus Vaccine, an Oxford Group Leaps Ahead

... As the pandemic exploded, grant money poured in. All other vaccines were soon put into the freezer so that the institute’s laboratory could focus full-time on Covid-19. Then the lockdown forced everyone not working on Covid-19 to stay home altogether.

... Other scientists involved in the project are working with a half dozen drug manufacturing companies across Europe and Asia to prepare to churn out billions of doses as quickly as possible if the vaccine is approved. None have been granted exclusive marketing rights, and one is the giant Serum Institute of India, the world’s largest supplier of vaccines.

Donors are currently spending tens of millions of dollars to start the manufacturing process at facilities in Britain and the Netherlands even before the vaccine is proven to work, said Sandy Douglas, 37, a doctor at Oxford overseeing vaccine production.

... But the team has not yet reached an agreement with a North American manufacturer,in part because the major pharmaceutical companies there typically demand exclusive worldwide rights before investing in a potential medicine.

“I personally don’t believe that in a time of pandemic there should be exclusive licenses,” Professor Hill said. “So we are asking a lot of them. Nobody is going to make a lot of money off this.”

https://www.nytimes.com/2020/04/27/world/europe/coronavirus-vaccine-update-oxford.html

5 replies = new reply since forum marked as read
Highlight: NoneDon't highlight anything 5 newestHighlight 5 most recent replies
Oxford Coronavirus Team: "Nobody is going to make a lot of money off this". (Original Post) denem Apr 2020 OP
"But the team has not yet reached an agreement with a North American manufacturer ..." Botany Apr 2020 #1
Trump's FDA will not approve a vaccine for the USA unless HE, and an American company, are allowed BComplex Apr 2020 #2
If the rest of the world has it denem Apr 2020 #4
Clearly SheltieLover Apr 2020 #3
That will royally piss off 45 who is wanting to profit from American vaccine licensing & production. LonePirate Apr 2020 #5

Botany

(70,476 posts)
1. "But the team has not yet reached an agreement with a North American manufacturer ..."
Tue Apr 28, 2020, 03:06 PM
Apr 2020

Too bad they didn't need a meat packing plant because Trump would be all over that "stuff."

Trump to Order U.S. Meat Plants to Stay Open Amid Pandemic

https://www.democraticunderground.com/10142481470

BComplex

(8,029 posts)
2. Trump's FDA will not approve a vaccine for the USA unless HE, and an American company, are allowed
Tue Apr 28, 2020, 03:12 PM
Apr 2020

to profit in the extreme.

 

denem

(11,045 posts)
4. If the rest of the world has it
Tue Apr 28, 2020, 03:17 PM
Apr 2020

dumpling may not have a choice - particularly if VP Biden is promising fast approval.

Latest Discussions»General Discussion»Oxford Coronavirus Team: ...